Critical Life Science
M&A Growth Strategies

Critical Life Science
M&A Growth Strategies

Top life science M&A leaders share strategies to prevent financial pitfalls & bad partnerships

Virtual CEO Strategy Roundtable

Tuesday, March 11 — 11:00am – 12:00pm EST

Meet with life science industry leaders for an exclusive strategy discussion on market expansion and value creation opportunities.

This is your chance to gain insider knowledge and make crucial connections that could define your company’s future.

Only 12 seats available for this exclusive session for C-Suite executives involved in the M&A process for mid-market life science companies.

$1B+ Invested Across
12 Platform Companies

Ashton Poole

Partner, QHP Capital

vitalink Website Headshots_Boyd Wainscott

CEO of 6 Global Companies, 23 Successful Acquisitions

Boyd Wainscott

President of M&A, Forma Life Science Marketing

vitalink Website Headshots_Jeanne Frazer

$20M+ EBITDA Transformation Expertise

Jeanne Frazer

Virtual CEO Strategy Roundtable

Tuesday, March 11 — 11:00am – 12:00pm EST

Meet with life science industry leaders for an exclusive strategy discussion on market expansion and value creation opportunities.

This is your chance to gain insider knowledge and make crucial connections that could define your company’s future.

Only 12 seats available for this exclusive session for C-Suite executives involved in the M&A process for mid-market life science companies.

$1B+ Invested Across 12 Platform Companies

Ashton Poole

Partner, QHP Capital

CEO of 6 Global Companies, 23 Successful Acquisitions

vitalink Website Headshots_Boyd Wainscott

Boyd Wainscott

President of M&A, Forma Life Science Marketing

$20M+ EBITDA Transformation Expertise

vitalink Website Headshots_Jeanne Frazer

Jeanne Frazer

Reserve your seat now!

Select Companies Transformed by Our Leaders

QHP Captial Logo
Azurity Pharmaceuticals Logo
Bend Bioscience Logo
ICI Logo
Novartis Logo
GlaxoSmithKline Logo
Biomerieux Logo
Montrose Environmental Logo
StageBio Logo

Select Companies Transformed by Our Leaders

QHP Captial Logo
Azurity Pharmaceuticals Logo
Bend Bioscience Logo
ICI Logo
ICI Logo
Novartis Logo
GlaxoSmithKline Logo
Biomerieux Logo
Biomerieux Logo
StageBio Logo
Montrose Environmental Logo

Reserve your seat now!

The 3 Most Valuable Insights

  • Gain insider knowledge and make crucial connections that could define your company’s future

  • Avoid common mistakes with first-hand insights from building and selling global companies, plus key criteria for acquisitions

  • Learn what makes your company irresistible to private equity firms and discover the perfect timing for PE engagement

Only 12 seats available for this exclusive session for C-Suite executives involved in the M&A process for mid-market life science companies.

Questions?

Reach out to Rosanne Brouette, our Vice President of Development!

vitalink Website Headshots_Rosanne Brouette